NewcelX Valuation
| NCEL Stock | 2.63 0.10 3.95% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. NewcelX secures a last-minute Real Value of USD2.52 per share. The latest price of the firm is USD2.63. Our model forecasts the value of NewcelX from analyzing the firm fundamentals such as Total Debt of 28.18 M, retained earnings of (74.43 M), and EBITDA of (3.63 M) as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that NewcelX's price fluctuation is dangerous at this time. Calculation of the real value of NewcelX is based on 3 months time horizon. Increasing NewcelX's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NewcelX stock is determined by what a typical buyer is willing to pay for full or partial control of NewcelX. Since NewcelX is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NewcelX Stock. However, NewcelX's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.63 | Real 2.52 | Hype 1.94 | Naive 1.39 |
The intrinsic value of NewcelX's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence NewcelX's stock price.
Estimating the potential upside or downside of NewcelX helps investors to forecast how NewcelX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NewcelX more accurately as focusing exclusively on NewcelX's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use NewcelX's intrinsic value based on its ongoing forecasts of NewcelX's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against NewcelX's closest peers.
NewcelX Cash |
|
NewcelX Total Value Analysis
NewcelX is now forecasted to have valuation of 0 with market capitalization of 0, debt of 28.18 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the NewcelX fundamentals before making equity appraisal based on enterprise value of the companyNewcelX Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of NewcelX suggests not a very effective usage of assets in December.NewcelX Profitability Analysis
Net Loss for the year was (1.98 M) with profit before overhead, payroll, taxes, and interest of 0.About NewcelX Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of NewcelX. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of NewcelX based exclusively on its fundamental and basic technical indicators. By analyzing NewcelX's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of NewcelX's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of NewcelX. We calculate exposure to NewcelX's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NewcelX's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -3.3 K | -3.5 K |
NewcelX Current Valuation Indicators
NewcelX's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final NewcelX's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NewcelX, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NewcelX's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NewcelX's worth.When determining whether NewcelX is a strong investment it is important to analyze NewcelX's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewcelX's future performance. For an informed investment choice regarding NewcelX Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewcelX. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in consumer price index. For more information on how to buy NewcelX Stock please use our How to buy in NewcelX Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewcelX. If investors know NewcelX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewcelX listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewcelX is measured differently than its book value, which is the value of NewcelX that is recorded on the company's balance sheet. Investors also form their own opinion of NewcelX's value that differs from its market value or its book value, called intrinsic value, which is NewcelX's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewcelX's market value can be influenced by many factors that don't directly affect NewcelX's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewcelX's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewcelX is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewcelX's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.